| 1 |
Ranasinghe WK, Suh N, Hughes PD. Survival outcomes in renal transplant recipients with renal cell carcinoma or transitional cell carcinoma from the ANZDATA database[J]. Exp Clin Transplant, 2016, 14(2):166-171.
|
| 2 |
Butler AM, Olshan AF, Kshirsagar AV, et al. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009[J]. Am J Kidney Dis, 2015, 65(5):763-772.
|
| 3 |
Agraharkar ML, Cinclair RD, Kuo YF, et al. Risk of malignancy with long-term immunosuppression in renal transplant recipients[J]. Kidney Int, 2004,66(1):383-389.
|
| 4 |
Andrés A．Cancer incidence after immunosuppressive treatment following kidney transplantation[J]. Crit Rev Oncol Hematol, 2005, 56(1): 71-85.
|
| 5 |
McDonald SP. Australia and New Zealand Dialysis and Transplant Registry[J]. Kidney Int Suppl，2015,5(1):39-44.
|
| 6 |
Zilinska Z, Sersenova M, Chrastina M, et al. Occurrence of malignancies after kidney transplantation in adults: Slovak multicenter experience[J]. Neoplasma, 2017,64(2):311-317.
|
| 7 |
粟大明，邓文锋，刘如敏，等. 肾移植术后新发恶性肿瘤：单中心经验[J]. 器官移植，2020,11(4):449-454.
|
| 8 |
Neuzillet Y, Lay F, Luccioni A, et al. De novo renal cell carcinoma of native kidney in renal transplant recipients[J]. Cancer, 2005, 103(2):251-257.
|
| 9 |
Filocamo MT, Zanazzi M, Li Marzi V, et al. Renal cell carcinoma of native kidney after renal transplantation: clinical relevance of early detection[J]. Transplant Proc, 2009, 41(10):4197-4201.
|
| 10 |
Végsö G, Toronyi E, Hajdu M, et al. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis[J]. Transplant Proc, 2011, 43(4):1261-1263.
|
| 11 |
Cheung CY, Lam MF, Lee KC, et al. Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature[J]. Int Urol Nephrol, 2011,43(3): 675-680.
|
| 12 |
Sun IO, Ko YM, Kim EY, et al. Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney[J]. Korean J Intern Med, 2013, 28(3):347-351.
|
| 13 |
Moon A, Rogers A, Talbot D, et a. Renal cell cancer in a European regional renal transplant population: is there a role for immediate native renal radiological surveillance before and after transplantation？[J]. Transplant Proc, 2015, 47(6):1840-1844.
|
| 14 |
Guleryuz K, Doerfler A, Codas R, et al. A national study of kidney graft tumor treatments: toward ablative therapy[J]. Surgery, 2016, 160(1):237-244.
|
| 15 |
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients[J]. Am J Transplant, 2009, 9(Suppl 3):S1-S155.
|
| 16 |
Dahle DO, Skauby M, Langberg CW, et al. Renal cell carcinoma and kidney transplantation: a narrative review[J]. Transplantation, 2022, 106(1): e52-e63.
|
| 17 |
Moris D, Kakavia K, Argyrou C, et al. De novo renal cell carcinoma of native kidneys in renal transplant recipients: a single-center experience[J]. Anticancer Res, 2017, 37(2):773-779.
|
| 18 |
Shen B, Cen Z, Tan M, et al. Current status of malignant tumors after organ transplantation[J]. Biomed Res Int, 2022, 2022:5852451.
|
| 19 |
Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours[J]. Eur Urol, 2016, 70(1): 93-105.
|
| 20 |
Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience[J]. J Clin Oncol, 2005, 23(12):2763-2771.
|
| 21 |
Minkovich M, Wong RBK, Famure O, et al. Renal cell carcinoma in kidney transplant recipients: incidence, trends, clinical management & outcomes[J]. World J Urol, 2023,41(9):2389-2395.
|
| 22 |
Klatte T, Seitz C, Waldert M, et al. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients[J]. BJU Int, 2010, 105(9):1260-1265.
|
| 23 |
Wong G, Howard K, Webster AC, et al. Screening for renal cancer in recipients of kidney transplants[J]. Nephrol Dial Transplant, 2011, 26(5):1729-1739.
|
| 24 |
李新长，龙成美，杨华，等. 肾移植术后新发恶性肿瘤17例临床分析[J/CD]. 中华移植杂志：电子版，2017,11(2):90-92.
|
| 25 |
Motta G, Ferraresso M, Lamperti L, et al. Treatment options for localised renal cell carcinoma of the transplanted kidney[J]. World J Transplant, 2020, 10(6):147-161.
|
| 26 |
Li XB, Xing NZ, Wang Y, et al. Transitional cell carcinoma in renal transplant recipients: a single center experience[J]. Int J Urol, 2008,15(1):53-57.
|
| 27 |
Du C, Zheng M, Wang Z, et al. Clinical characteristics and treatment outcomes of kidney transplant recipients with de novo urothelial carcinoma: thirty years of experience from a single center[J]. BMC Urol, 2023, 23(1):71.
|
| 28 |
Zhang A, Shang D, Zhang J, et al. A retrospective review of patients with urothelial cancer in 3，370 recipients after renal transplantation: a single-center experience[J]. World J Urol, 2015,33(5):713-717.
|
| 29 |
Liu S, Chaudhry MR, Berrebi AA, et al. Polyomavirus replication and smoking are independent risk factors for bladder cancer after renal transplantation[J]. Transplantation, 2017,101(6):1488-1494.
|